Imprimis Njof recalls

Imprimis Njof has 21 recalls on record with the FDA and USDA, the earliest in 2021 and the latest reported on 14 Jan 2026. 15 are still ongoing. 4 were reported in the last 12 months. The most frequent reason is sterility.

Total recalls21since 2021

Last 12 months4reported

Class I00% of total

Ongoing15latest 14 Jan 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 1 0May 0 2 0Aug 0 0 1Nov 0 3 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 14 67%Class III 7 33%

Why imprimis njof is recalled

Product types

By year

2026314%
2025419%
20241048%
2023314%
202115%

Ongoing imprimis njof recalls

15 active

Reported	Class	Recall	Company	Reason	Where
14 Jan 2026Drug	CLASS II	Dexamethasone Moxifloxacin, 1 mg/mL recalled by Imprimis NJOF	Imprimis Njof	Particulate Matter	Nationwide
14 Jan 2026Drug	CLASS II	Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL recalled	Imprimis Njof	Particulate Matter	Nationwide
14 Jan 2026Drug	CLASS II	Tri-Moxi+¿ (Triamcinolone 9mg recalled by Imprimis NJOF	Imprimis Njof	Particulate Matter	Nationwide
26 Nov 2025Drug	CLASS III	Klarity-C Drops (Cyclosporine) recalled by Imprimis NJOF	Imprimis Njof	Potency & Assay	Nationwide
9 Apr 2025Drug	CLASS III	Tropicamide - Proparacaine - Phenylephrine recalled by Imprimis NJOF	Imprimis Njof	Potency & Assay	FL, NY
19 Jun 2024Drug	CLASS II	Klarity-C (cyclosporine) Preservative-Free Sterile recalled	Imprimis Njof	Sterility	Nationwide

All imprimis njof recalls, newest first

21 total

Reported	Class	Recall	Company	Reason	Where
14 Jan 2026Drug	CLASS II	Dexamethasone Moxifloxacin, 1 mg/mL recalled by Imprimis NJOF	Imprimis Njof	Particulate Matter	Nationwide
14 Jan 2026Drug	CLASS II	Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL recalled	Imprimis Njof	Particulate Matter	Nationwide
14 Jan 2026Drug	CLASS II	Tri-Moxi+¿ (Triamcinolone 9mg recalled by Imprimis NJOF	Imprimis Njof	Particulate Matter	Nationwide
26 Nov 2025Drug	CLASS III	Klarity-C Drops (Cyclosporine) recalled by Imprimis NJOF	Imprimis Njof	Potency & Assay	Nationwide
30 Jul 2025Drug	CLASS II	Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, mL Vials recalled	Imprimis Njof	Potency & Assay	Nationwide
30 Jul 2025Drug	CLASS III	Tropicamide-Proparacaine-Phenylephrine-Ketorolac recalled	Imprimis Njof	Potency & Assay	Nationwide
9 Apr 2025Drug	CLASS III	Tropicamide - Proparacaine - Phenylephrine recalled by Imprimis NJOF	Imprimis Njof	Potency & Assay	FL, NY
19 Jun 2024Drug	CLASS II	Klarity-C (cyclosporine) Preservative-Free Sterile recalled	Imprimis Njof	Sterility	Nationwide
19 Jun 2024Drug	CLASS II	Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic recalled	Imprimis Njof	Sterility	Nationwide
5 Jun 2024Drug	CLASS II	Epinephrine-Lidocaine HCl 0.25 mg/mL recalled by Imprimis NJOF	Imprimis Njof	Sterility	Nationwide
5 Jun 2024Drug	CLASS II	Dexamethasone-Moxifloxacin (1 mg/mL recalled by Imprimis NJOF	Imprimis Njof	Sterility	Nationwide
5 Jun 2024Drug	CLASS II	Epinephrine-Lidocaine HCl 0.25 mg/mL recalled by Imprimis NJOF	Imprimis Njof	Sterility	Nationwide
5 Jun 2024Drug	CLASS II	Moxifloxacin 0.8 mg/ Preservative-Free Single-Use vials recalled	Imprimis Njof	Sterility	Nationwide
5 Jun 2024Drug	CLASS II	Moxifloxacin 4 mg/ Preservative-Free Single-Use vials recalled	Imprimis Njof	Sterility	Nationwide
5 Jun 2024Drug	CLASS II	Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL recalled	Imprimis Njof	Sterility	Nationwide
8 May 2024Drug	CLASS III	Epinephrine-Lidocaine HCl 0.25 mg/mL recalled by Imprimis NJOF	Imprimis Njof	Potency & Assay	Nationwide
8 May 2024Drug	CLASS II	Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac recalled	Imprimis Njof	Potency & Assay	Nationwide
25 Oct 2023Drug	CLASS III	Mydriatic-4: Tropicamide - Proparacaine - Phenylephrine recalled	Imprimis Njof	Potency & Assay	Nationwide
11 Oct 2023Drug	CLASS III	Epinephrine-Lidocaine HCl (0.25mg/mL recalled by Imprimis NJOF	Imprimis Njof	Potency & Assay	Nationwide
30 Aug 2023Drug	CLASS III	Moxifloxacin - Bromfenac Sterile Ophthalmic Solution recalled	Imprimis Njof	Potency & Assay	Nationwide
6 Jan 2021Drug	CLASS II	Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL recalled	Imprimis Njof	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.